Podcast: US FDA’s Artificial Intelligence Guidance May Need Congress And Is At Least A Year Away, Expert Says
• By Ferdous Al-Faruque
AdvaMed's Zach Rothstein working at his office in Washington, D.C. As the top lobbyist for AI/ML, he's working to get US FDA on the same page as industry. • Source: Ferdous Al-Faruque
Keep up with the top medtech business and regulatory news.
Medtech Insight brings you interviews and analysis, on the go.
